tm logo

Monitor this mark

View On USPTO

SDCORD
Dead/Cancelled
CANCELLED – SECTION 71

on 31 May 2024

Last Applicant/ Owned by

Glycostem Therapeutics B.V.

Antoni van Leeuwenhoek Building, Kloosterstraat 9, NL-5349 AB Oss

NL

Serial Number

79208840 filed on 30th Mar 2017

Registration Number

5332245 registered on 14th Nov 2017

in the Principal Register

Correspondent Address

Michael M. Morris

Michael M. Morris Woodard Emhardt Moriarty McNett & Henry LLP

Suite 3700

Indianapolis, IN 46204

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

SDCORD

Cell products for treating cancer, namely, cells for medical use in the field of immuno-oncology

Classification Information

Class [005]
Pharmaceutical Products

Cell products for treating cancer, namely, cells for medical use in the field of immuno-oncology

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79208840

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 84028-2

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
31st May 2024CANCELLED SECTION 71
08th Dec 2023NEW REPRESENTATIVE AT IB RECEIVED
14th Nov 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
24th May 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
13th Apr 2018FINAL DECISION TRANSACTION PROCESSED BY IB
20th Feb 2018FINAL DISPOSITION NOTICE SENT TO IB
20th Feb 2018FINAL DISPOSITION PROCESSED
14th Feb 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14th Nov 2017REGISTERED-PRINCIPAL REGISTER
29th Aug 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED